arrow
J

Jane N. Winter

northwestern university
H指数:62
被引数:1.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Validation and Clinical Meaningfulness of the 18-item National Comprehensive Cancer Network-Functional Assessment of Cancer Therapy (NCCN-FACT) Lymphoma Symptom Index (NFLymSI-18) in Patients with Lymphoma

18项国家综合癌症网络-癌症治疗功能评估(NCCN-FACT)淋巴瘤症状指数(NFLymSI-18)在淋巴瘤患者中的验证及其临床意义

2026-04-170
PRE
Outcomes of Bispecific Antibodies After CAR T-Cell Failure for Large B-cell Lymphoma- Results from the ABC Consortium

大B细胞淋巴瘤在CAR T细胞治疗失败后使用双特异性抗体的疗效——ABC Consortium研究的结果

2025-10-240
OAAI
Nivolumab in Combination with R-CHOP for Treatment-Naïve Diffuse Large B-Cell Lymphoma: An Evaluation of Safety and Efficacy

纳武利尤单抗联合R-CHOP方案治疗初治弥漫性大B细胞淋巴瘤:安全性与有效性的评估

2025-07-280
OAAI
Clinical Outcomes of Transformed Follicular Lymphoma with CAR T-Cell Therapy: A US Multicenter Real-World Analysis

CAR T细胞疗法治疗转化型滤泡性淋巴瘤的临床结局:一项美国多中心真实世界分析

BLOOD
IF23.1
2024-11-050
PRE
Impact of race and social determinants of health on outcomes in patients with aggressive B-cell NHL treated with CAR-T therapy
2024-05-285
OAAI
Subsequent malignant neoplasms in patients previously treated with anti-CD19 CAR T-cell therapy
2024-05-166
OAAI
Single-cell double expression of MYC and BCL2 proteins by fluorescent multiplex IHC is mainly in lymphoma cells with significant prognostic impact in large B-cell lymphoma while suggesting high cutoffs for routine IHC
2024-03-220
PRE
Outcomes of patients with secondary central nervous system lymphoma following CAR T-cell therapy: a multicenter cohort study

CAR T细胞治疗后继发性中枢神经系统淋巴瘤患者的结局: 一项多中心队列研究

2023-11-0911
OAAI
Peri-CAR-T practice patterns and survival predictors for all CAR-T patients and post-CAR-T failure in aggressive B-NHL

所有car-t患者和侵袭性b-nhl的car-t后失败的围术期实践模式和生存预测指标

2023-06-1427
OAAI
EBV-positive DLBCL frequently harbors somatic mutations associated with clonal hematopoiesis of indeterminate potential
2023-04-0310
OAAI
Hodgkin Lymphoma, Version 2.2022 Featured Updates to the NCCN Guidelines
2022-04-0142
OA
Determining clinical course of diffuse large B-cell lymphoma using targeted transcriptome and machine learning algorithms
2022-02-0111
OAAI
Genomic complexity is associated with epigenetic regulator mutations and poor prognosis in diffuse large B-cell lymphoma

弥漫性大b细胞淋巴瘤中基因组复杂性与表观遗传调节基因突变和不良预后相关

2021-07-207
OAAI
Aggressive B-cell Lymphoma with MYC/TP53 Dual Alterations Displays Distinct Clinicopathobiological Features and Response to Novel Targeted Agents
2021-02-0328
OAAI